Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Definium Therapeutics, Inc. | 211,057 | reported | 25 Mar 2024 | tx 14+6,340,000−48,609 |
| Avalo Therapeutics, Inc. | 3,883 | reported | 10 Dec 2021 | tx 3+502,883 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Mar 2024 | TAX_WITHHOLDING | Definium Therapeutics, Inc. | 5,560 | 9.78 USD | |
| 27 Feb 2024 | GRANT_AWARD | Definium Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 26 Dec 2023 | SALE | Definium Therapeutics, Inc. | 5,652 | 3.63 USD | |
| 25 Sept 2023 | SALE | Definium Therapeutics, Inc. | 3,854 | 3.58 USD | |
| 25 Sept 2023 | SALE | Definium Therapeutics, Inc. | 1,908 | 3.57 USD | |
| 25 Aug 2023 | SALE | Definium Therapeutics, Inc. | 20,000 | 3.80 USD | |
| 27 Jun 2023 | SALE | Definium Therapeutics, Inc. | 7,694 | 3.19 USD | |
| 27 Jun 2023 | SALE | Definium Therapeutics, Inc. | 3,941 | 3.21 USD | |
| 14 Mar 2023 | GRANT_AWARD | Definium Therapeutics, Inc. | 175,000 | 0.00 USD | |
| 23 May 2022 | GRANT_AWARD | Definium Therapeutics, Inc. | 1,270,000 | 0.00 USD | |
| 23 May 2022 | GRANT_AWARD | Definium Therapeutics, Inc. | 1,650,000 | 0.00 USD | deriv |
| 10 Dec 2021 | PURCHASE | Avalo Therapeutics, Inc. | 2,231 | 1.57 USD | |
| 10 Jun 2021 | PURCHASE | Avalo Therapeutics, Inc. | 652 | 2.68 USD | |
| 01 Mar 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 500,000 | 0.00 USD | deriv |